Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-11
DOI
10.1038/s41598-018-37433-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Membrane particles generated from mesenchymal stromal cells modulate immune responses by selective targeting of pro-inflammatory monocytes
- (2017) Fabiany da C. Gonçalves et al. Scientific Reports
- Potentiation of TRAIL killing activity by multimerization through isoleucine zipper hexamerization motif
- (2016) Ji Hye Han et al. BMB Reports
- Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors
- (2016) Lei Miao et al. CANCER RESEARCH
- Onto better TRAILs for cancer treatment
- (2016) D de Miguel et al. CELL DEATH AND DIFFERENTIATION
- Preclinical Biosafety Evaluation of Genetically Modified Human Adipose Tissue-Derived Mesenchymal Stem Cells for Clinical Applications to Brainstem Glioma
- (2016) Seung Ah Choi et al. STEM CELLS AND DEVELOPMENT
- Engineered adenovirus fiber shaft fusion homotrimer of soluble TRAIL with enhanced stability and antitumor activity
- (2016) J Yan et al. Cell Death & Disease
- Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial
- (2015) Hanno Niess et al. BMC CANCER
- Restoration of TRAIL-induced apoptosis in resistant human pancreatic cancer cells by a novel FAK inhibitor, PH11
- (2015) P. Dao et al. CANCER LETTERS
- Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer
- (2015) C. J. Whatcott et al. CLINICAL CANCER RESEARCH
- Pancreatic cancer: current understanding of molecular and genetic aetiologies
- (2015) Tamara M H Gall et al. POSTGRADUATE MEDICAL JOURNAL
- Bypassing the need for pre-sensitization of cancer cells for anticancer TRAIL therapy with secretion of novel cell penetrable form of Smac from hA-MSCs as cellular delivery vehicle
- (2015) Mohsen Khorashadizadeh et al. TUMOR BIOLOGY
- A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing
- (2015) Malvina Prapa et al. Oncotarget
- Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes
- (2015) Wanchun Shi et al. BioScience Trends
- TRAIL Mediated Signaling in Pancreatic Cancer
- (2014) Daniele Rubert Nogueira et al. Asian Pacific Journal of Cancer Prevention
- Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the Death Receptor pathway
- (2014) Zhiyu Chen et al. CANCER LETTERS
- Getting TRAIL back on track for cancer therapy
- (2014) J Lemke et al. CELL DEATH AND DIFFERENTIATION
- Mesenchymal stem cells, cancer challenges and new directions
- (2014) Nedime Serakinci et al. EUROPEAN JOURNAL OF CANCER
- TRAIL-secreting mesenchymal stem cells promote apoptosis in heat-shock-treated liver cancer cells and inhibit tumor growth in nude mice
- (2014) Q Deng et al. GENE THERAPY
- Surrounding Pancreatic Adenocarcinoma by Killer Mesenchymal Stromal/Stem Cells
- (2014) Giulia Golinelli et al. HUMAN GENE THERAPY
- Immunoglobulin Fc Domain Fusion to TRAIL Significantly Prolongs Its Plasma Half-Life and Enhances Its Antitumor Activity
- (2014) H. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Influence of the Implantation Site on the Sensitivity of Patient Pancreatic Tumor Xenografts to Apo2L/TRAIL Therapy
- (2014) Rohit Sharma et al. PANCREAS
- Therapeutic options for the management of pancreatic cancer
- (2014) Maria L Rossi WORLD JOURNAL OF GASTROENTEROLOGY
- TRAIL negatively regulates VEGF-induced angiogenesis via caspase-8-mediated enzymatic and non-enzymatic functions
- (2013) Hee-Jun Na et al. ANGIOGENESIS
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- APG350 Induces Superior Clustering of TRAIL Receptors and Shows Therapeutic Antitumor Efficacy Independent of Cross-Linking via Fc Receptors
- (2013) C. Gieffers et al. MOLECULAR CANCER THERAPEUTICS
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss of TRAIL-Receptors Is a Recurrent Feature in Pancreatic Cancer and Determines the Prognosis of Patients with No Nodal Metastasis after Surgery
- (2013) Eike Gallmeier et al. PLoS One
- TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells
- (2012) M R Moniri et al. CANCER GENE THERAPY
- Gene therapy in B-NHL cell line using adenovirus-mediated transfer of secretable trimeric TRAIL gene expression driven by CD20 promoter
- (2012) Xiang-Fei Yuan et al. EXPERIMENTAL HEMATOLOGY
- The role of stroma in pancreatic cancer: diagnostic and therapeutic implications
- (2012) Mert Erkan et al. Nature Reviews Gastroenterology & Hepatology
- Pancreatic ductal adenocarcinoma screening: New perspectives
- (2012) Raffaele Pezzilli WORLD JOURNAL OF GASTROENTEROLOGY
- A novel combination of TRAIL and doxorubicin enhances antitumor effect based on passive tumor-targeting of liposomes
- (2011) Liangran Guo et al. NANOTECHNOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy
- (2010) Giulia Grisendi et al. CANCER RESEARCH
- TRAIL-Induced Apoptosis Is Preferentially Mediated via TRAIL Receptor 1 in Pancreatic Carcinoma Cells and Profoundly Enhanced by XIAP Inhibitors
- (2010) D. Stadel et al. CLINICAL CANCER RESEARCH
- Mesenchymal stromal cells alone or expressing interferon-β suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment
- (2010) Shannon Kidd et al. CYTOTHERAPY
- A Genetically Encoded Multifunctional TRAIL Trimer Facilitates Cell-Specific Targeting and Tumor Cell Killing
- (2010) D. Spitzer et al. MOLECULAR CANCER THERAPEUTICS
- Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?
- (2010) H. Schrezenmeier et al. VOX SANGUINIS
- Engineering a leucine zipper-TRAIL homotrimer with improved cytotoxicity in tumor cells
- (2009) D. V. Rozanov et al. MOLECULAR CANCER THERAPEUTICS
- Adult Stromal Cells Derived from Human Adipose Tissue Provoke Pancreatic Cancer Cell Death both In Vitro and In Vivo
- (2009) Beatrice Cousin et al. PLoS One
- Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
- (2009) L. S. Sasportas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma
- (2008) B M Beckermann et al. BRITISH JOURNAL OF CANCER
- Stem cells are resistant to TRAIL receptor-mediated apoptosis
- (2008) Eva Szegezdi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started